Molecules / Bimatoprost

Bimatoprost API manufacturers

CAS 155206-00-1 ATC S01EE03 Updated 9 July 2026
13
manufacturers with an active filing 12 of them hold a US DMF or a CEP
15
shortage records on file across 5 countries
405
finished-dose makers across 52 regulators
Showing 13 of 13 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

FDC

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2024. Its 2023 FDA inspection closed as NAI, and its GMP is recognised in 16 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · NAI
GMP recognised in
16 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
02

MSN Laboratories

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
26 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
03

EUROAPI

Hungary
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2015. Its 2019 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2019 · NAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

YS Life Science

South Korea
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2011. Its 2025 FDA inspection closed as NAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · NAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
05

ScinoPharm Taiwan

Taiwan
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2013. Its 2022 FDA inspection closed as NAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2022 · NAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
06

Chirogate International

Taiwan
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2025 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
07

Industriale Chimica

Italy
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2010. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2022 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
08

Kyowa Pharma Chemical

Japan
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2008. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
None on file
Last FDA inspection
2022 · VAI
GMP recognised in
1 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
09

Newchem

Italy
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2025. Its 2023 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
10

Cayman Pharma Sro

Czech Republic
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2011.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
11

Everlight Chemical Industrial

Taiwan
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2008.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
12

Johnson Matthey Pharma Services

United States
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for bimatoprost, filing since 2007.

US DMF
1 active
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
13

Registered with PMDA (Japan) for bimatoprost.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

10 more manufacturers hold filings for bimatoprost

The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.

YS Life ScienceScinoPharm TaiwanChirogate InternationalIndustriale ChimicaKyowa Pharma ChemicalNewchemCayman Pharma SroEverlight Chemical IndustrialJohnson Matthey Pharma ServicesEverlightChemicalIndustrialCorporation
Open the full list with a free account

Contract manufacturers (7)

Rafarm Greece Genetic S. P. A Italy Lgm Pharma United States Indoco Remedies Ethiopia C2 Pharma Ireland Dr Vmr Labs India Everlight Chemical Ind Taiwan

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (48)

Abbvie United States Apotex Canada Sandoz Switzerland Micro Labs India Théa PHARMA France Zentiva, k.s Czech Republic Alembic Pharmaceuticals India Viatris United States Allergan Produtos Farmaceuticos Ltda Brazil Ajanta Pharma India HIKMA ITALIA Italy Gilead Sciences United States Laboratorios Salvat S A Spain Amneal Pharmaceuticals NY United States Jamp Pharma Canada Juno Pharma Canada Canada Lupin India Rafarm Greece STADA Arzneimittel Germany Aculife Healthcare India

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators

Map bimatoprost for your markets

Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.

Start for free
No sales call.

Also on this molecule

Shortages 15 Recalls 6 Finished dose 48 Contract mfrs 7

By country

Taiwan 8

Sold in these combinations

Bimatoprost + Timolol 2 APIs

Fixed-dose combinations containing bimatoprost. Each page leads with the verified API makers of every component.